Skip Navigation

Cardiovascular Research 2003 60(1):58-67; doi:10.1016/S0008-6363(03)00348-1
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Kleijn, D.
Right arrow Articles by Pasterkamp, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Kleijn, D.
Right arrow Articles by Pasterkamp, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Toll-like receptors in cardiovascular diseases

Dominique de Kleijna,b,* and Gerard Pasterkampa

aExperimental Cardiology Laboratory, University Medical Center (G02 523), Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
bInteruniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, The Netherlands

*Corresponding author. Tel.: +31-30-250-7155; fax: +31-30-252-2693. Email address: d.dekleijn{at}hli.azu.nl

The Toll-like receptor family recognizes mostly exogenous ligands like bacterial lipopolysaccharides or DNA and activates the inflammatory cell. Evidence is accumulating that these Toll-like receptors are important in cardiovascular pathologies. Recently, expression of Toll-like receptors in arterial and myocardial cells has been shown and mouse knockout and human studies on polymorphisms point to a role of Toll-like receptor 4 in neointima formation and atherosclerosis. It is now becoming clear that these receptors not only serve as receptors for pathogen-associated molecular patterns but are also involved in the initiation and progression of cardiovascular pathologies.

KEYWORDS Atherosclerosis; Receptors; Infection/Inflammation; Arteries; Immunology


Time for primary review 36 days.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
E Cockrell, R. Espinola, and K. McCrae
Annexin A2: biology and relevance to the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 944 - 952.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Ruppert, T. Meyer, S. Pankuweit, E. Moller, R. C. Funck, W. Grimm, B. Maisch, and German Heart Failure Network
Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 360 - 369.e1.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Takahashi
Toll-like receptors and myocardial contractile dysfunction
Cardiovasc Res, April 1, 2008; 78(1): 3 - 4.
[Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
S. K. Sze, D. P. V. de Kleijn, R. C. Lai, E. Khia Way Tan, H. Zhao, K. S. Yeo, T. Y. Low, Q. Lian, C. N. Lee, W. Mitchell, et al.
Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells
Mol. Cell. Proteomics, October 1, 2007; 6(10): 1680 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Erridge, C. M. Spickett, and D. J. Webb
Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2
Cardiovasc Res, January 1, 2007; 73(1): 181 - 189.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Shimamoto, A. J. Chong, M. Yada, S. Shomura, H. Takayama, A. J. Fleisig, M. L. Agnew, C. R. Hampton, C. L. Rothnie, D. J. Spring, et al.
Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury
Circulation, July 4, 2006; 114(1_suppl): I-270 - I-274.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. K. Mohammad, M. Morran, B. Slotterbeck, D. W. Leaman, Y. Sun, H. v. Grafenstein, S.-C. Hong, and M. F. McInerney
Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse
Int. Immunol., July 1, 2006; 18(7): 1101 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. van Oort and L. J. De Windt
TOLL-erating cardiac hypertrophy following pressure overload
Cardiovasc Res, November 1, 2005; 68(2): 178 - 179.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Razmara, D. N. Krause, and S. P. Duckles
Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1843 - H1850.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Petersen, K. A. Krumholz, and B. A. Burleigh
Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi
Infect. Immun., October 1, 2005; 73(10): 6974 - 6980.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. S. Michelsen, M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
PNAS, July 20, 2004; 101(29): 10679 - 10684.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Li, T. Ha, J. Kelley, X. Gao, Y. Qiu, R. L Kao, W. Browder, and D. L Williams
Modulating Toll-like receptor mediated signaling by (1->3)-{beta}-D-glucan rapidly induces cardioprotection
Cardiovasc Res, February 15, 2004; 61(3): 538 - 547.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Calabrese, A. C van der Wal, and M. Levi
Infection and inflammation in the cardiovascular system
Cardiovasc Res, October 15, 2003; 60(1): 1 - 4.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.